Boots Reportedly Entertains $10 Billion Sale Amid IPO Talks

Boots, the 175-year-old British pharmacy and beauty retailer, is at the center of a bidding process that could value the chain at up to $10 billion. The company’s owners — Sycamore Partners and Italian entrepreneur Stefano Pessina — are weighing a sale against a previously planned initial public offering, according to sources close to the negotiations. The potential deal has drawn interest from the Canadian branch of the billionaire Weston family, which operates the Shoppers Drug Mart chain in Canada.

For the broader beauty and fashion retail industry, the outcome matters beyond the deal itself. Boots’ strategy for the next decade — whether as a publicly traded company or under private ownership — will shape how other pharmacy-anchored beauty retailers approach the balance between healthcare and commerce. The sale process is expected to conclude by the end of the third quarter.

Boots occupies a unique position in British retail. Its high-street pharmacies serve millions of NHS prescription customers, while its beauty halls compete directly with department stores and specialty retailers. The dual identity has made it difficult to categorize — investors who like the pharmacy margins are often uncomfortable with the capital intensity of beauty retail, and vice versa.

The sale talks mark a significant shift in strategy. An IPO had been the preferred exit route since Pessina and Sycamore acquired the chain from Walgreens in a leveraged buyout two years ago. But the reception to recent retail IPOs has been uneven, and a direct sale to a strategic buyer would offer certainty of valuation and a cleaner exit for the private equity backers.

The Weston family’s interest is particularly telling. Their Shoppers Drug Mart chain in Canada operates on a similar model — pharmacy anchored by front-end beauty sales — and has weathered the disruption of the past decade better than most of its peers. A Boots acquisition would give the Westons a platform to apply their pharmacy-retail playbook in a new market, while Sycamore would exit with what sources describe as a strong return on its initial investment.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close